ABT-147

• Target:

  Interleukin

• Related Pathways:

  Immunology/Inflammation

• Bioactivity:

  ABT-147 is a humanized IgG1 monoclonal antibody inhibitor targeting IL-12. It is utilized in researching autoimmune diseases such as rheumatoid arthritis (RA), inflammatory diseases like inflammatory bowel disease (IBD), and other conditions including asthma.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C